This compound is primarily used in the pharmaceutical industry as an intermediate in the synthesis of complex drug molecules. Its unique structure, featuring a difluoromethyl group and a cyclopropane ring, makes it valuable for developing biologically active compounds, particularly those targeting enzymes or receptors. The tert-butoxycarbonyl (Boc) protecting group ensures selective reactivity during synthetic processes, enabling precise modifications in multi-step drug synthesis. Applications include the development of antiviral, anticancer, or anti-inflammatory agents, where the difluoromethyl group can enhance metabolic stability and binding affinity. Its cyclopropane moiety also contributes to conformational rigidity, which is crucial for optimizing drug-target interactions.